Ignite Creation Date:
2024-05-06 @ 3:18 PM
Last Modification Date:
2024-10-26 @ 1:47 PM
Study NCT ID:
NCT04587388
Status:
RECRUITING
Last Update Posted:
2020-10-14
First Post:
2020-10-08
Brief Title:
Towards Personalized Medicine for RefractoryRelapsed Follicular Lymphoma Patients the CanteraLupiae Registry
Sponsor:
Organization:
European Hematology Association - Lymphoma Group
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
True
Target Duration:
5 Years
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITHOUT_DNA
Bio Spec Description:
Histological block or slides for confirming the diagnosis This analysis will be conducted retrospectively
Enrollment Count:
500
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Cohort |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 69163 |
Who Masked List: